Impact Biomedical (IBO) Inventory Average (2025 - 2026)

Impact Biomedical's (IBO) quarterly Inventory Average came in at $63000.0 in Q1 2026, down 77.01% on a QoQ basis from $274000.0 in Q4 2025.

Impact Biomedical (IBO) Inventory Average (2025 - 2026) Analysis & Trends

Impact Biomedical (IBO) has 2 years of Inventory Average data on file, last reported at $63000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	3.09 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	213.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	707.10 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	90.57 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	137.65 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	196.36 Mn
10	Impact Biomedical	49.45 Mn	49.44 Mn	2,000.00	62,500.00

Download Data